ImmuCell Corporation (ICCC)

ImmuCell Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr 2, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	49	46	39	47	62	43
Market Cap Growth	16.33%	16.33%	-16.51%	-23.70%	44.31%	15.59%
Enterprise Value	56	58	54	51	62	48
Last Close Price	5.00	5.15	5.09	6.10	8.00	5.95
PS Ratio	1.54	1.73	2.26	2.55	3.22	2.80
PB Ratio	1.63	1.74	1.58	1.56	1.90	1.52
P/TBV Ratio	1.75	1.75	1.59	1.56	1.91	1.53
P/OCF Ratio	125.49	-	-	-	64.91	32.62
EV/Sales Ratio	2.12	2.17	3.10	2.76	3.22	3.13
EV/EBITDA Ratio	38.69	55.17	-	65.78	22.78	49.62
EV/EBIT Ratio	-	-	-	240.62	-
Debt / Equity Ratio	0.59	0.59	0.67	0.41	0.32	0.38
Debt / EBITDA Ratio	14.87	14.87	-	12.96	3.57	9.69
Asset Turnover	-	-	0.39	0.42	0.45	0.39
Inventory Turnover	-	-	1.89	2.26	4.09	3.68
Quick Ratio	-	-	0.76	2.47	5.09	4.44
Current Ratio	-	-	2.73	4.56	6.42	5.50
Return on Equity (ROE)	-8.39%	-8.39%	-20.86%	-7.92%	-0.26%	-3.57%
Return on Assets (ROA)	-	-	-7.36%	-2.39%	0.38%	-2.18%
Return on Capital (ROIC)	-2.45%	-2.45%	-7.72%	-2.49%	0.39%	-2.26%
Return on Capital Employed (ROCE)	-	-	-	-	0.60%	-
Earnings Yield	-4.80%	-4.70%	-14.64%	-5.28%	-0.13%	-2.38%
FCF Yield	-	-16.64%	-11.68%	-2.67%	-6.42%
Buyback Yield / Dilution	-5.41%	-5.41%	-0.03%	-2.01%	-5.25%	-5.78%

Updated Feb 25, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q